{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001130113.1:c.90G>C",
          "cDNA Change": {
            "transcript": "NM_001130113.1",
            "ref": "G",
            "alt": "C",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein (SNCA) associated with enhanced fibrillization and altered conformation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005319"
  },
  "Experiment Method": [
    {
      "Assay Method": "Electron microscopy",
      "Material used": {
        "Material Source": "Protein samples",
        "Material Name": "Alpha-synuclein fibrils",
        "Description": "Analysis of fibril morphology and fragmentation in A30P mutant vs. wild-type"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130113.1:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced fibrillization and fragmentation",
          "Result Description": "A30P mutant fibrils showed increased fragmentation compared to wild-type controls"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein fibrils used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No fibrils (blank sample) used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No fragmentation observed in wild-type controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Increased fragmentation observed in A30P mutant",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ultracentrifugation",
      "Material used": {
        "Material Source": "Protein samples",
        "Material Name": "Alpha-synuclein fibrils",
        "Description": "Analysis of fibril sedimentation and solubility in A30P mutant vs. wild-type"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130113.1:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered sedimentation behavior",
          "Result Description": "A30P mutant fibrils exhibited different sedimentation profiles compared to wild-type"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein fibrils used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No fibrils (blank sample) used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Sedimentation profile consistent with wild-type controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Sedimentation profile deviating from wild-type controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunochemical analysis with epitope-specific antibodies",
      "Material used": {
        "Material Source": "Protein samples",
        "Material Name": "Alpha-synuclein fibrils",
        "Description": "Analysis of conformational changes in A30P mutant vs. wild-type"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130113.1:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Distinct conformational changes",
          "Result Description": "Epitope-specific antibodies detected altered conformation in A30P mutant fibrils"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein fibrils used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No fibrils (blank sample) used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Epitope-specific antibody binding consistent with wild-type controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Epitope-specific antibody binding altered in A30P mutant",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Biochemical analysis of protease-resistant cores",
      "Material used": {
        "Material Source": "Protein samples",
        "Material Name": "Alpha-synuclein fibrils",
        "Description": "Analysis of protease resistance in A30P mutant vs. wild-type"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130113.1:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered protease resistance",
          "Result Description": "A30P mutant fibrils showed distinct protease resistance patterns compared to wild-type"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein fibrils used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No fibrils (blank sample) used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protease resistance profile consistent with wild-type controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protease resistance profile deviating from wild-type controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}